Becton, Dickinson and Company (NYSE:BDX) is one of the top stocks that Grok recommended. On July 31, Becton, Dickinson and ...

The U.S. services sector growth unexpectedly slowed in July, as new orders barely shifted and hiring continued to slide.

A newly FDA-approved, at-home test kit from Teal Health called the Teal Wand aims to break down some of those barriers and ...

Guyana has acquired Merck-made 9-valiant HPV (human papilloma virus) vaccines at a very low cost through a deal negotiated by the Pan-American Health Organisation (PAHO), according to Health Minister ...

Telix Pharmaceuticals stock drops as SEC probes disclosures tied to cancer treatment Jul. 23, 2025 5:12 AM ET Telix Pharmaceuticals Limited (TLX) Stock, TLPPF Stock By: Arundhati Sarkar, SA News ...

Replimune stock (ticker: REPL) cratered on Tuesday after the biotech said the U.S. Food and Drug Administration rejected an application seeking approval of its experimental skin cancer treatment.

Replimune (REPL) stock in focus as the FDA rejects its lead drug RP1 as part of a combination regimen for melanoma, a type of skin cancer. Read more here.

Replimune stock fell after the FDA rejected its RP1 application, citing flaws in the trial design and lack of substantial evidence for approval.

Tislelizumab combined with chemotherapy shows promising antitumor activity in advanced cervical cancer, achieving high response rates and manageable safety profiles.

Health Canada Approves KEYTRUDA® for the treatment of adult patients with FIGO 2014 Stage III-IVA cervical cancer, in combination with chemoradiotherapy (CRT)¹ ...

Introduction: Cervical cancer is the fourth most common malignancy in women and is primarily caused by persistent infection with high-risk human papillomavirus (HPV). In addition, host immune ...

Browse 22,700+ pink watercolor background stock illustrations and vector graphics available royalty-free, or search for purple pink watercolor background or pink watercolor background vector to find ...